CDH17 and cancer: Dysregulation of cadherins, particularly E-cadherin, is implicated in the loss of cell adhesion, leading to increased cellular motility, invasion, and metastasis, which are hallmarks of cancer progression (Bryan, 2015; Sousa, Pereira & Paredes, 2019; Lin, Cooper & Anastasiadis, 2023).